CommentIndividualised management of malignant pleural effusion
References (15)
- et al.
Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion
Chest
(2005) - et al.
Prognostic significance of pleural fluid data in patients with malignant effusion
Eur J Intern Med
(2008) - et al.
Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B
Chest
(1998) - et al.
Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study
Lancet Oncol
(2008) - et al.
Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515
Lung Cancer
(2007) Point: should pleural manometry be performed routinely during thoracentesis? Yes
Chest
(2012)- et al.
Counterpoint: should pleural manometry be performed routinely during thoracentesis? No
Chest
(2012)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2015 Elsevier Ltd. All rights reserved.